Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (14)

2022

  1. Evidence of telomere attrition and a potential role for DNA damage in systemic sclerosis

    Immunity and Ageing, Vol. 19, Núm. 1

2020

  1. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: A multicentric matched cohort study

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 12, pp. 1544-1549

  2. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 9, pp. 1170-1173

2014

  1. Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: Case-control study

    Arthritis Research and Therapy, Vol. 16, Núm. 1

2009

  1. Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-κB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility

    Arthritis Research and Therapy, Vol. 11, Núm. 2

  2. Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, Eotaxin-3, and MHC2TA

    Journal of Rheumatology, Vol. 36, Núm. 8, pp. 1590-1595

  3. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors

    Arthritis and Rheumatism, Vol. 60, Núm. 9, pp. 2558-2564

2008

  1. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 5, pp. 631-637

2006

  1. SUMO4 and MAP3K7IP2 single nucleotide polymorphisms and susceptibility to rheumatoid arthritis

    Journal of Rheumatology, Vol. 33, Núm. 6, pp. 1048-1051

2003

  1. CARD15/NOD2 analysis in rheumatoid arthritis susceptibility

    Rheumatology, Vol. 42, Núm. 11, pp. 1380-1382

1999

  1. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5

    Arthritis and Rheumatism, Vol. 42, Núm. 5, pp. 989-992

  2. Cyclooxygenase-1 and -2 are expressed by human T cells

    Clinical and Experimental Immunology, Vol. 115, Núm. 1, pp. 86-90

  3. Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis

    Journal of Pathology, Vol. 188, Núm. 1, pp. 63-68

  4. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation

    Journal of Rheumatology, Vol. 26, Núm. 3, pp. 588-590